MiNK Therapeutics, Inc. (INKT) Q1 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-05-15 16:50:43 ET
MiNK Therapeutics, Inc. (INKT) Q1 2026 Earnings Call May 15, 2026 8:30 AM EDT
Company Participants
Stefanie Perna-Nacar
Jennifer Buell - Co-Founder, President, CEO & Director
Terese Hammond - Head of Inflammatory & Pulmonary Diseases
Melissa Orilall - Principal Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
MiNK Therapeutics, Inc. (INKT) Q1 2026 Earnings Call Transcript
MiNK Therapeutics Inc.
NASDAQ: INKT
INKT Trading
-3.92% G/L:
$12.38 Last:
24,304 Volume:
$12.66 Open:
INKT Latest News
May 28, 2026 09:04:49 am
MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness
INKT Stock Data
$94,552,132
3,709,418
0.69%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
